The European Medicines Agency (EMA) on Friday approved a new manufacturing site in France for the production of Moderna Inc's Covid-19 vaccine.
The site at Monts will be operated by Recipharm and produce the finished product, the EMA's committee for human medicines (CHMP) said.
Earlier this month, the CHMP approved two new sites in the United States to produce both active substance and the finished product for Moderna's vaccine.
It expects these moves to allow production of an additional one million to two million vials of ready-to-use vaccine for the European Union market every month.
Moderna already has a deal with Thermo Fisher Scientific's commercial manufacturing site in Greenville, North Carolina that will support production of "hundreds of millions" of doses.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Hundreds of Ukrainians surrender at Azovstal after last stand: Russia
Russia won't simply put up with Nato's Nordic expansion, Ryabkov says
Ukraine prepares for new Russian Donbas push, says gains made in north
Sweden and Finland take ‘historic’ steps toward Nato membership
Ukraine rappers boost war morale with Eurovision win
Finland to apply for Nato membership: president, PM
Macron starts second term with challenges mounting
Ukraine wages counter offensive against Russian forces in east
G7 'will never recognise' borders changed by force by Russia